Benzinga - Feed Your Mind.

Market Overview

(:) Offerings

Benzinga Professional

7:38 AM Cytokinetics Reports Early Termination of HSR Waiting Period for Expanded Collaboration with Astellas; Upfront Payment of $65M from Astellas Due, Payable Within 30 Days
7:37 AM Genocea Shares to Resume Trade at 8 a.m. EDT
7:36 AM Stephens & Co. Initiates Coverage on Sunoco Logistics Partners at Overweight, Announces $35.00 PT
7:36 AM Roth Capital Initiates Coverage on Knowles at Buy
7:36 AM Arrowhead Pharma Shares to Resume Trade at 8 a.m. EDT
7:35 AM TASER Reports Vegas Metro Police Has Deployed 1,604 TASER X26P Smart Weapons, No Terms Disclosed
07:35 AM 9 Stocks Which Rallied Three Days On Increasing Volume
7:35 AM Karyopharm Reports Publishing of Preclinical Data Show Selinexor's Potential in KRAS-Mutant NSCLC
7:34 AM Stein Mart Reports Dawn Robertson Resigned as CEO; Pres, COO D. Hunt Hawkins Named Interim Replacement at CEO
7:33 AM UPDATE: Amgen Will Receive Global Exclusive License to Arrowhead's RNAi ARC-LPA Program
7:32 AM UPDATE: Arrowhead Will Receive $56.5M in Upfront Payments, Up to Added $617M in Potential Milestones
7:32 AM Amgen, Arrowhead Pharma Report Two Cardiovacular Collaborations
7:32 AM Citigroup Initiates Coverage on H.B. Fuller at Buy, Announces $53.00 PT
07:31 AM Sarepta Dosing First Patients In Phase 3 Trial Of Duchenne Muscular Dystrophy Drug
7:31 AM Genocea Reports Phase 2b Trial of GEN-003 for Genital Herpes Met Primary Endpoint, Dose is Confirmed for Subsequent Trials

1	TWTR, SPY: Poll: Donald Trump Won The Debate
2	BLDP, ARRY: 15 Stocks Moving In Tuesday's Pre-Market Session
3	AVXL, TPX: 18 Stocks Moving In Wednesday's Pre-Market Session
4	TWTR: 12 Best Tweets From Monday's Presidential Debate
5	GOOG, GOOGL: Alphabet Downgraded, Target Cut To $7...
6	NKE, UA: Nike Is In The Midst Of A Nort...
7	SRPT: RBC's Bullish Neurolo...

1	F, UNP: Is Donald Trump Trying To Kill This Rail Stock?
2	ATW, RIG: Can You Guess This Chart?
3	MKSI, JMBA: 9 Stocks Which Rallied Three Days On Increasing Volume
4	SRPT: Sarepta Dosing First Patients In Phase 3 Trial Of Du...
5	PEP: Investors Cheer PepsiCo's Q3 Results, Outlook
6	FTV: Fortive's Expected Growth Is Priced In
7	AB, FOMX: 8 Stocks Which Plummeted Three Days On...